| Date | Title | Description |
| 12.03.2026 | Replit Achieves $9 Billion Valuation, Leads AI-Powered Software Revolution | Replit secured $400 million, catapulting its valuation to $9 billion. This AI-powered platform revolutionizes software development. It lets users rapidly build, deploy, and monetize applications. No traditional coding mastery is required. R... |
| 11.03.2026 | Vitestro Secures $70 Million to Revolutionize Blood Collection | Vitestro secured $70 million in Series B funding. This capital fuels autonomous robotic blood collection. The Aletta system automates venipuncture with AI, multimodal imaging, and robotics. It aims for precise, consistent blood draws. This ... |
| 11.03.2026 | Replit: $400 Million Series D At $9 Billion Valuation Raised To Expand AI Software Creation Platform | Replit announced it has raised $400 million in a Series D funding round led by Georgian and backed by investors including G Squared, Prysm Capital, 1789 Capital, Y Combinator, Coatue, Andreessen Horowitz, Craft Ventures, and Qatar Investmen... |
| 10.03.2026 | Vitestro: $70 Million Raised To Advance Autonomous Robotic Blood Collection Technology | Vitestro, a Netherlands-based medical robotics company developing autonomous blood-drawing technology, has raised $70 million in an oversubscribed Series B financing round to accelerate development of its robotic phlebotomy platform and exp... |
| 03.02.2026 | Prenosis Secures $40M, Fuels AI Revolution in Critical Care | Prenosis secured $40M to transform critical care. A $20M Series A funds commercialization of Sepsis ImmunoScore, the FDA-authorized AI sepsis diagnostic. A $20M BARDA contract backs a pivotal trial for an AI companion diagnostic for cortico... |
| 02.02.2026 | Prenosis Raises $20M in Series A Funding | Prenosis, a Chicago, IL-based biology-based technology company delivering integrated diagnostics and therapeutics, raised $20M in Series A funding.
The round was led by PACE Healthcare Capital, with premier co-investors including UC Investm... |
| 29.01.2026 | Prenosis Secures $40M to Build the Precision Medicine Network for Critical Care | What You Should Know
The News: Prenosis has secured a combined $40M in new capital—split evenly between a $20M Series A led by PACE Healthcare Capital and a $20M federal contract from BARDA.
The Tech: The funding supports the commercial rol... |
| 21.01.2026 | BIOMAKERS Raises Additional $8 Million To Scale Global Precision Oncology Intelligence Platform | BIOMAKERS, a San Francisco-headquartered precision medicine and oncology intelligence company, announced it has closed an additional $8 million in financing as it shifts from building diagnostics and data infrastructure to scaling an AI-nat... |
| 14.01.2026 | IMVARIA Secures Strategic Investments for AI-Driven Lung Diagnostics | IMVARIA, a Berkeley health tech innovator, secured strategic funding. New capital expands its AI-driven diagnostic services for lung diseases. InHealth Ventures led the round. Labcorp Venture Fund and Cedar Crest Holdings participated. IMVA... |
| 08.01.2026 | IMVARIA Announces Strategic Investments For AI-Based Digital Biomarker Solutions | IMVARIA, a Berkeley, California-based health tech company developing AI-driven digital biomarker solutions, announced it has secured strategic investments from new and existing investors to accelerate growth and expand its AI-powered diagno... |
| 08.01.2026 | IMVARIA Raises Funding | IMVARIA, a Berkeley, CA-based health tech company, raised an undisclosed amount in funding.
The round was led by InHealth Ventures with participation from the Labcorp Venture Fund and existing partner Cedar Crest Holdings.
The company inten... |
| 16.12.2025 | Cofactor Genomics Receives Investment from Labcorp and Ascension Ventures | Cofactor Genomics, a St. Louis, MO-based commercial-stage diagnostics company, received an investment from Labcorp and Ascension Ventures.
The amount of the deal was not disclosed.
The company intends to use the funds to support continued e... |
| 16.12.2025 | Cofactor Genomics Secures Strategic Investment From Labcorp And Ascension Ventures | Cofactor Genomics has received strategic investments from Labcorp and Ascension Ventures to accelerate nationwide expansion of its OncoPrism® immunotherapy response diagnostic and broaden patient access across U.S. cancer care networks.
The... |
| 20.11.2025 | Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research | , a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, announced a collaborative initiative to accelerate innovation in digital pathology (... |
| 14.11.2025 | Clear Labs Showcases Oncology NGS Automation Initiatives and Announces Collaboration with Labcorp | Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and toward scalable, in-house genomic testing... |
| 12.11.2025 | Laboratory Economics Issues Research Report on U.S. Anatomic Pathology Market | Laboratory Economics has just published the most comprehensive and detailed market research report available on the U.S. Anatomic Pathology Market. This is an ideal resource for preparing business plans and market strategies.
POUGHKEEPSIE, ... |
| 07.11.2025 | Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025 | Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery
SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Lunit (KRX:328130), a ... |
| 07.11.2025 | SiteLabs Raises $2M in Seed Funding | SiteLabs, a Clemson, SC-based is a health technology startup turning independent pharmacies into community-based hubs for preventive care and clinical research, raised $2M in Seed funding
The round was led by Boomerang Ventures with partici... |
| 06.11.2025 | IgniteData: $11 Million Series A Raised To Expand Global Clinical Data Automation Platform | IgniteData has completed the final close of its oversubscribed Series A funding round, bringing the total capital raised to $11 million. The investment will support the company’s continued global expansion, product development, and innovati... |
| 05.11.2025 | IgniteData Raises Series A Funding | IgniteData, a New Castle, DE-based company which specializes in intelligent clinical trial data automation, raises an undisclosed amount in funding.
The round was led by FCA Venture Partners, with participation from Labcorp Venture Fund and... |
| 25.09.2025 | Living Security Unveils HRMCon 2025 Speakers as Report Finds Firms Detect Just 19% of Human Risk | Share
Share
Share
Share
Email
Living Security, a global leader in Human Risk Management (HRM), today announced the full speaker lineup for the Human Risk Management Conference (HRMCon 2025), taking place October 20, 2025, at Austin’s Q2 Sta... |
| 25.09.2025 | Life Sciences Decoded Launches Video Content Platform to Help Biotech and Healthcare Leaders Win Buyers' Trust and Accelerate Growth | Life Sciences Decoded's Video Content Platform Helps Biotech & Healthcare Leaders Win Buyers’ Trust and Accelerate Growth
Veteran industry executives Susan Najjar, MS, MBA and Meghan O'Sullivan bring decades of experience guiding compan... |
| 19.09.2025 | LabConnect Appoints Bill Finger as Senior Vice President, Global Strategic Services | JOHNSON CITY, Tenn., Sept. 19, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Bill Finger as Senior Vice President, Global Strategic Services, effective Wednesday, September 10, 2025.
Bill brings more than 25 year... |
| 10.09.2025 | Mercy BioAnalytics: $59 Million Closed To Advance Early Cancer Detection With Liquid Biopsy | Mercy BioAnalytics has announced the successful close of a $59 million Series B funding round to accelerate the development and commercialization of its early cancer detection technologies. The round was co-led by Novalis and Sozo Ventures,... |
| 03.09.2025 | Mercy BioAnalytics Raises $59M in Series B Funding | Mercy BioAnalytics, a Waltham, MA-based company which specializes in extracellular vesicle-based liquid biopsies for the early detection of cancer, raised $59M in Series B funding.
The round was led by Novalis and Sozo Ventures, with partic... |
| 30.07.2025 | Labcorp Launches GenAI Tool to Simplify Lab Test Selection for Healthcare Providers | Image Credit: Labcorp
What You Should Know:
– Labcorp announced the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS).
– Designed to simplify lab test selection, Test Finder enables healt... |
| 30.06.2025 | Noul Publishes Its Fifth Sustainability Report, Outlining a Vision for Growth and a Decade of Breakthroughs | "The next decade will focus on securing strong growth momentum by strengthening product competitiveness and profitability"
First technology-special listed company to join the Corporate Value-Up Program… "We will grow by faith... |
| 20.06.2025 | The Surge of Precision Medicine: A New Era in Cancer Diagnostics | In the world of healthcare, precision medicine is the lighthouse guiding us through the fog. It promises tailored treatments, turning the tide against diseases like cancer. Recent funding rounds for companies like PreciseDx and GeneCentric ... |
| 19.06.2025 | PreciseDx Raises $11M in Additional Funding | PreciseDx, the NYC-based provider of PreciseBreast, a breast cancer diagnostic that is empowered by OncoIntelligence, its proprietary AI-platform, raised $11M in additional fundin.
The round was led by Eventide Asset Management, Merck Globa... |
| 18.06.2025 | GeneCentric Therapeutics Holds Initial Closing of $8.0M Series C Financing | GeneCentric Therapeutics, a Durham, NC-based company advancing precision medicine through gene expression, announced the initial closing of an $8.0m Series C financing.
The round was led by Hatteras Venture Partners, with current participat... |
| 01.06.2025 | Outcomes4Me: Pioneering the Future of Cancer Care with AI Innovation | In the ever-evolving landscape of healthcare, Outcomes4Me stands as a beacon of hope for cancer patients. The Boston-based company recently secured $21 million in funding, a significant boost that will accelerate its mission to transform ca... |
| 31.05.2025 | Outcomes4Me: $21 Million Secured For Advancing AI-Based Cancer Care Innovation | Outcomes4Me – a developer of the leading direct-to-patient and AI-based platform transforming the cancer care experience – announced the closing of a $21 million funding round. With this round, Outcomes4Me welcomes a new investor, London-ba... |
| 30.05.2025 | Outcomes4Me Secures $21Million in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Care | Outcomes4Me Inc., the developer of the leading direct-to-patient, AI-driven platform transforming the cancer care experience, today announced the close of a $21M funding round.
“AI will reshape cancer care, and this investment accelerates o... |
| 20.05.2025 | Frame and Labcorp Expands Access to Fertility Testing and Care | What You Should Know:
– Frame, the collaborative care platform transforming access to reproductive and fertility care, announced a strategic collaboration with Labcorp, a global leader in innovative and comprehensive laboratory services.
– ... |
| 09.05.2025 | Startup Teal Health wins FDA approval for at-home test for cervical cancer screening | The FDA approved the first at-home test for cervical cancer screening, developed by Teal Health.
In clinical trials, the accuracy of self-testing with Teal’s wand matched that of a cancer screening performed in a doctor’s office.
Teal will ... |
| 05.05.2025 | CND Life Sciences: Pioneering Neurodiagnostics with $13.5 Million Boost | In the ever-evolving landscape of healthcare, innovation is the lifeblood that fuels progress. CND Life Sciences, a neurodiagnostics startup based in Scottsdale, Arizona, has just secured a significant financial boost of $13.5 million in it... |
| 04.05.2025 | CND Life Sciences: $13.5 Million Series A Closed For Neurodiagnostics Innovations | CND Life Sciences announced that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most recent Series A3 offering. CND’s latest Series A3 round included funding from existing investor groups like C... |
| 12.04.2025 | Olaris and Labcorp: A New Era in Precision Medicine | In the world of healthcare, precision is key. Olaris, Inc., a company based in Framingham, Massachusetts, is making waves in this arena. They are not just another player; they are innovators. Their focus? Metabolomics and machine learning. ... |
| 11.04.2025 | Olaris Receives Investment from Labcorp | Olaris, Inc., a Framingham, MA-based precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARIS™ diagnostics products, received an investment from Labcorp, a global leader of in... |
| 11.04.2025 | Olaris: Strategic Investment Raised From Labcorp | Olaris, a precision medicine company leveraging metabolomics and machine learning to discover and develop its myOLARIS diagnostics products, announced an investment from Labcorp, a leader of innovative and comprehensive laboratory services,... |
| 05.04.2025 | Singapore’s healthtech startup Mito Health raised $2.2 M Seed funding | With plans to build an AI preventive health doctor, Singapore-based Mito Health has raised an additional $2.2 million in seed funding, bringing its total funds raised to $4 million.
“We want to extend our gratitude to our new investors — Y ... |
| 13.03.2025 | Junction Secures $18M to Revolutionize Healthcare Infrastructure | In a world where healthcare is often a tangled web of outdated systems, Junction is stepping in with a fresh approach. The company recently announced an impressive $18 million Series A funding round, led by Creandum, with support from notab... |
| 12.03.2025 | Cost Free Program for Behavioral Health Hospitals to Secure HEDIS Stars by Meeting New NCQA Mental Health Guidelines | Providing an integrated program to minimize avoidable readmissions.
M3 Checklist Empowers Behavioral Health Hospitals to Meet the new HEDIS Star Requirements with Cutting-Edge Measurement.
We support providers and health systems with our Pr... |
| 11.03.2025 | Empirical Health Launches "Health Radar," a Doctor-Designed Health Score Combining Wearable and Lab Data | Empirical Health Radar -- works with Apple Watch and WearOS watches
Today, Empirical Health announces the launch of Empirical Health Radar, a doctor-developed health score that distills over 40 biomarkers from Apple Watch, WearOS devices, a... |
| 11.03.2025 | Junction Raises $18M Series A to build better healthcare infrastructure that improves patient experience | New York, United States, March 11th, 2025, FinanceWire
Junction, a healthcare infrastructure company, has announced an $18 million Series A funding round led by Creandum, with participation from Y Combinator, Point Nine, Amino Collective, a... |
| 23.01.2025 | Percipio Health: A New Dawn in Population Health Monitoring | In the vast landscape of healthcare, innovation often feels like a mirage. Yet, Percipio Health emerges as a beacon of hope. This new platform, powered by artificial intelligence, has just raised $20 million in Series A funding. The backers... |
| 22.01.2025 | Percipio Health Raises $20M in Funding | Percipio Health, a Dallas, TX-based population health monitoring and management platform, raised $20M in funding.
Backers included UPMC Enterprises, WAVE Ventures, Labcorp, and First Trust Capital Partners.
The company intends to use the fu... |
| 22.01.2025 | Percipio Health raises $20M and unveils AI-powered Population Health Monitoring platform | The platform collects and analyzes multiple health signals via smartphone, without medical monitoring devices, to reach broader populations at lower costs, while reducing risk and advancing value-based care.
Percipio Health, a population he... |
| 21.01.2025 | Percipio: AI-Based Population Health Monitoring Platform Raises $20 Million | Percipio Health, a population health monitoring and management platform that is scalable across rising and high-risk categories, announced its official launch and $20 million raised to date with the closing of its series A, from investors i... |
| 21.01.2025 | Percipio Health Launches AI-Powered Population Health Platform with $20M | What You Should Know:
– Percipio Health, a population health monitoring and management platform, today announced its official launch and the closing of a $20M in Series A funding round led by UPMC Enterprises, WAVE Ventures, and Labcorp.
– ... |
| 17.01.2025 | Breaking Barriers: Innovations in Fertility and Women’s Health | In the realm of health, two recent initiatives shine a light on the pressing need for accessible care. The BIVF Foundation and Teal Health are tackling significant challenges in fertility and cervical cancer screening. Both organizations ar... |
| 17.01.2025 | Teal Health: $10 Million (Seed) Closed To Launch Wand For At-Home Cervical Cancer Screening | Teal Health, a women’s health company with a goal of eliminating cervical cancer in the US, announced the closing of an additional $10 million in seed funding to support the upcoming launch of the Teal Wand, which is currently under FDA rev... |
| 16.01.2025 | Teal Health Raises $10M, Launches the First At-Home Cervical Cancer Screening | What You Should Know:
– Teal Health, a women’s health company dedicated to eliminating cervical cancer, announced today it has raised an additional $10M in seed funding led by Emerson Collective and Forerunner, with continued support from e... |
| 16.01.2025 | BIVF Foundation Announces New Round of Fertility and Family Building Grants to Support Parenthood Aspirations | The BIVF Foundation has launched its 2025 Family Building and Fertility Grant cycle, providing financial assistance to individuals and couples pursuing fertility treatments and family building services, reaffirming the foundation's mission ... |
| 10.01.2025 | Geneoscopy: $105 Million (Series C) Raised For Developing Advanced Gastrointestinal Diagnostic Tests | Geneoscopy – a life sciences company focused on developing diagnostic tests for advancing gastrointestinal health – announced the closing of a Series C funding round raising $105 million. Bio-Rad Laboratories led the financing and was joine... |
| 09.01.2025 | Geneoscopy's Bold Leap: $105M Series C Funding Fuels Gastrointestinal Diagnostics Revolution | In the world of healthcare, innovation is the lifeblood. Geneoscopy, a St. Louis-based life sciences company, has just injected a hefty $105 million into its veins through a Series C funding round. This financial boost is not just a number;... |
| 08.01.2025 | Geneoscopy Closes $105M in Series C Funding | Geneoscopy, a St. Louis, MO-based life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, raised $105M in Series C funding.
The round was led by Bio-Rad Laboratories (NYSE: BIO and BIO.B)... |
| 08.01.2025 | Geneoscopy closes $105M in Series C funding round to power next-generation of gastrointestinal diagnostic tests | Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease
ST. LOUIS & HERCULES, Calif. – Jan. 8, 2025 — Geneoscopy, I... |
| 20.11.2024 | Genetic Testing Delivers Startup Hits And Misses | 3 Shares Email Facebook Twitter LinkedIn
When submitting a genetic test, one usually has a desired outcome in mind. That doesn’t mean the results will bear it out.
Investing in DNA testing startups is much the same. Over the years, startup ... |
| 20.11.2024 | Developing Predictive Cancer Models and More Persistent CAR T-cell Therapies through Enhanced Metabolic Fitness, Upcoming Webinar Hosted by Xtalks | www.labcorp.com
In this free webinar, learn about parameters that limit the efficacy of current chimeric antigen receptor (CAR) T-cell therapies and enable the development of CAR T-cells with enhanced performance. Attendees will learn how t... |
| 13.11.2024 | Navigating the Future of Healthcare: Praia Health and ICF's Strategic Moves | In the ever-evolving landscape of healthcare, two companies are making waves. Praia Health and ICF are reshaping how patients interact with health systems and how companies strategize growth. Their recent moves signal a shift towards more p... |
| 12.11.2024 | Innovations in Laboratory Testing for Decentralized Clinical Trials and Optimizations for Future, Upcoming Webinar Hosted by Xtalks | www.labcorp.com
In this free webinar, learn about the role decentralized and patient-centric testing plays in enhancing patient recruitment, retention and engagement. Attendees will learn how a direct-to-patient logistics network can enable... |
| 08.11.2024 | ICF hires former Labcorp exec to lead corporate development | ICF has hired a new vice president of corporate development in Dr. Eric Hakimov, who will help lead the company’s acquisition efforts and integration processes after the purchases close.
The company said Monday that Hakimov will work with o... |
| 08.11.2024 | Praia Health: Strategic Investment Raised From Labcorp Venture | Praia Health, a consumer experience orchestration platform for health systems, announced it has secured a strategic investment from the Labcorp Venture Fund and will collaborate with Labcorp, a leader of innovative and comprehensive laborat... |
| 07.10.2024 | Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases, Upcoming Webinar Hosted by Xtalks | www.labcorp.com
In this free webinar, learn about the rapidly evolving landscape of Alzheimer's disease therapy development and treatment. Attendees will gain insights into the key considerations for various platforms and strategies to inco... |
| 03.10.2024 | Considerations on the Evolving Testing Requirements for Environmental Fate Studies, Upcoming Webinar Hosted by Xtalks | www.labcorp.com
In this free webinar, learn how the regulatory landscape is changing with a shift to evaluate more complex chemicals. Attendees will learn how the nature of these complex chemical substances presents challenges in performing... |
| 22.08.2024 | PreciseDx's $20.7 Million Boost: A New Dawn for AI in Cancer Diagnostics | In the world of oncology, every second counts. PreciseDx, a trailblazer in cancer diagnostics, has just secured a significant lifeline. The company raised $20.7 million in Series B funding, bringing its total funding to $31.5 million. This ... |
| 21.08.2024 | PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments | What You Should Know:
– PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, Ge... |
| 31.07.2024 | Pendo Accelerates AI Roadmap with Acquisition of Customer Intelligence Platform Zelta AI | Announces strong early adoption of AI features now available across the Pendo One platform
RALEIGH, N.C. and NEW YORK, July 31, 2024 /PRNewswire/ -- Pendo, the all-in-one product experience platform, today announced that it has acquired Zel... |
| 17.05.2024 | Revolutionizing Obesity Treatment with Precision Medicine | Phenomix Sciences, a cutting-edge biotechnology company, has secured a whopping $7.8 million in funding to accelerate the adoption of precision medicine in the treatment of obesity. This influx of capital, including $5.5 million in Series A... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption | What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and La... |
| 14.03.2024 | Global Medical Device Outsourcing Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors | Medical Device Outsourcing Global Market Report 2024 : Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Medical Device Outsourcing Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2... |
| 12.03.2024 | Clinical Laboratory Services Market Projected to Reach $286.77 Billion by 2030, Driven by Advances in Disease Diagnosis and Increasing Geriatric Population | - |
| 12.03.2024 | Durham’s Fortrea to divest two businesses for $345M | Fortrea, a global contract research organization (CRO) that was spun off of Burlington-based Labcorp in 2023, will divest two of its businesses to focus more on supporting clinical drug development in phases 1 through 4.
Fortrea, headquarte... |
| 14.11.2023 | Ovia Health Launches New Fertility, Family-Building Offering | About one in six people globally battle infertility, according to the World Health Organization. That’s why Ovia Health by Labcorp is launching a new fertility and family-building benefit for employers and health plans, the company announce... |
| 27.09.2023 | FemTech: Evvy Raises $14M to Revolutionize Precision Women’s Healthcare | What You Should Know:
Evvy, a female-founded startup unlocking precision women’s healthcare through biomarker discovery, announced today the closing of a $14 million Series A funding round led by Left Lane Capital.
The round also includes G... |
| 07.08.2023 | New Diagnostics and Emerging Biomarkers for Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars This webinar will illuminate recent advancements, discuss the establishment of the ATN research framework and delve into how this new paradigm is revolutionizing the understanding and treatment of Alzheimer’s di... |
| 13.06.2023 | Non-Invasive Approaches to NAFLD/NASH Drug Development, Upcoming Webinar Hosted by Xtalks | Gain valuable knowledge about the latest NASH biomarkers and their practical applications in clinical settings.
TORONTO (PRWEB) June 13, 2023
This webinar will focus on non-invasive approaches to NAFLD/NASH drug development. During the webi... |
| 09.06.2023 | Proteomedix set for growth | |
| 01.02.2023 | The 11th Annual Lake Nona Impact Forum Returns to Address Health Innovation in the New Reality | Dr. Sanjay Gupta speaking at the 2022 Lake Nona Impact Forum in Lake Nona, Orlando, Florida. “Since its inception 11 years ago, Lake Nona Impact Forum’s North Star is to inspire human potential through health and wellbeing innovation,” said... |
| 17.10.2022 | Redi.Health Sees Tremendous Growth for Platform that Empowers Patients to Understand, Manage and Track their Health with Digital Support | Technology is revolutionizing healthcare, which is an industry that is long overdue for innovation. Redi.Health is helping simplify an extremely complex industry so patients can take more control of their healthcare journey.
COLUMBUS, Ohio ... |
| 13.10.2022 | NfL in Real-World Clinical Settings, Upcoming Webinar Hosted by Xtalks | Clinicians are beginning to use NfL and are learning about how it can provide useful and important information for patient care.
TORONTO (PRWEB) October 13, 2022
Neurofilament light chain (NfL) protein has been well studied in a broad array... |
| 14.07.2022 | Connecticut Department Of Public Health Provides Update On Monkeypox; Case Count Now Up To 11 | Press Releases
07/14/2022 Connecticut Department Of Public Health Provides Update On Monkeypox; Case Count Now Up To 11
FOR IMMEDIATE RELEASE: July 14, 2022
CONTACT: Chris Boyle, Director of Communications
(860) 706-9654 – christopher.boyle... |
| 12.07.2022 | Redi.Health Collaborates with Labcorp to Seamlessly Connect Patients and Providers | This collaboration is a significant steppingstone for the future of how patients will be able to manage their health and connect to pharmaceutical stakeholders.
COLUMBUS, Ohio (PRWEB) July 12, 2022
Today, Redi.Health, provider of health man... |
| 29.04.2022 | Teladoc’s 2022 Q1 earnings reveal a slowdown—but its chronic care business could rev it back up | The news: Teladoc reported that its Q1 year-over-year revenue grew 25% from $453.7 million in 2021 to $565.4 million in 2022.
However, Teladoc execs lowered their expected revenue for the full 2022 year: Now they expect $2.4 billion to $2.5... |
| 21.04.2022 | Portfolio Company Xcellbio expands Labcorp Collaboration for Cell & Gene Therapies | Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of cell and gene therapy technologies has expanded its collaboration with Labcorp to advance critical work that helps clients effectively bring innovative cell and gene therapies to ... |
| 09.04.2022 | Constellation Brands and Murphy Oil Raise Payouts in a Quiet Week for Dividend Hikes | Constellation Brands and Murphy Oil were among the small number of companies that declared dividend increases this week.
In addition, Laboratory Corp. of America Holdings (ticker: LH) initiated a quarterly dividend of 72 cents a share. Labc... |
| 01.04.2022 | Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials | What You Should Know:
- Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata’s technology platform to extend their 14-year partnership, the foundation of their in... |
| 22.02.2022 | Tenth Annual Lake Nona Impact Forum Convenes Health And Wellbeing Thought Leaders In Orlando, Florida | Deepak Chopra speaks during the Lake Nona Impact Forum “There’s no doubt we live in a different world since the arrival of COVID-19,” said Impact Forum Co-Founder Gloria Caulfield. “This year’s Impact Forum is critical as we gather some of ... |
| 10.02.2022 | Laboratory of America : Labcorp Announces 2021 Fourth Quarter and Full-Year Results Company Provides 2022 Guidance and Longer-Term Outlook (2022-2024) - Form 8-K | Labcorp Announces 2021 Fourth Quarter and Full-Year Results
Company Provides 2022 Guidance and Longer-Term Outlook (2022-2024)
•Revenue: Q4 of $4.1 billion, versus $4.5 billion last year; Full year of $16.1 billion, versus $14.0 billion las... |
| 03.02.2022 | A Review of Current Biomarkers for Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks | The featured speakers will discuss the positives and challenges in testing for these individual markers and how these tests might be used in clinical trials now and in the clinic in the future.
TORONTO (PRWEB) February 03, 2022
It seems tha... |
| 15.11.2021 | Labcorp Opens New Integrated Laboratory, Strengthens Bioanalytical Services In Asia-Pacific | SINGAPORE, Nov. 15, 2021 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its global offerings and its footprint in the Asia-Pacific (APAC) region with the opening of a new, integr... |
| 04.11.2021 | Immuno-Oncology – Converting Cancer to a “Chronic Disease,” Upcoming Webinar Hosted by Xtalks | This subpopulation of patients tends to lead a life with cancer as a chronic disease rather than a terminal illness.
TORONTO (PRWEB) November 04, 2021
The treatment of a cancer patient with immunotherapies offers unparalleled innovation tha... |
| 03.11.2021 | Uncovering the Regulatory Advice Affecting OECD 443 Study Design and the Impact on Your Ongoing and Future Studies, Upcoming Webinar Hosted by Xtalks | These recommendations have resulted in the necessity to amend the design of ongoing and planned studies ultimately affecting resources, time and cost of a study which was already complex and costly.
TORONTO (PRWEB) November 03, 2021
The Ext... |
| 02.11.2021 | Addressing Low Detection of Chronic Kidney Disease in At-Risk Patients, Upcoming Webinar Hosted by Xtalks | Hear first-hand from a patient on how early detection can improve outcomes for patients and their families.
TORONTO (PRWEB) November 02, 2021
One in three adults in the US have risk factors for developing CKD, a gradual loss of kidney funct... |
| 28.10.2021 | Labcorp Announces 2021 Third Quarter Results Company Raises Full-Year Guidance - Form 8-K | Labcorp Announces 2021 Third Quarter Results
Company Raises Full-Year Guidance
•Revenue: Q3 of $4.1 billion, versus $3.9 billion last year
•Diluted EPS: Q3 of $6.05, versus $7.17 last year
•Adjusted EPS: Q3 of $6.82, versus $8.41 last year
... |
| 04.10.2021 | FDA authorizes Labcorp’s at-home test kit for Covid-19, flu | Pixel received emergency use authorization for an at-home combined Covid-19 and flu test kit. Credit: Labcorp
The Food and Drug Administration gave the green light to Labcorp’s at-home combination test for Covid-19 and influenza A and B. Th... |
| 02.09.2021 | Labcorp : Raises Minimum Hourly Wage to $15 Per Hour | Labcorp (NYSE: LH), a leading global life sciences company, today announced it has increased the minimum hourly wage for United States (U.S.)-based, non-union employees to $15, effective September 2021.
This press release features multimedi... |
| 16.08.2021 | M&A: Labcorp Acquires Ovia Health to Expand Women’s Health Capabilities | What You Should Know:
– Labcorp has announced the acquisition of femtech startup Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy, and parenting. Financial deta... |
| 16.08.2021 | Use of Large Real-World Datasets to Improve Practice Guidelines and Clinical Study Designs in Metabolic Diseases, Upcoming Webinar Hosted by Xtalks | Practically speaking, these data can provide insights to help drive improvements in healthcare delivery.
TORONTO (PRWEB) August 16, 2021
Over the last decade, the collection and analysis of personal medical data has expanded and has been ap... |
